Skip to content
Home/Companies/Biotech/Oxford Cancer Analytics

Oxford Cancer Analytics

Biotech·UK·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Oxford Cancer Analytics?

Oxford Cancer Analytics is currently owned by EKA Ventures through Eka Ventures Fund I (2021 vintage), since 2022.

Hand-verified · updated 2026-06-30

EKA Ventures
Investor
EKA Ventures
Eka Ventures Fund I · 2021 · Impact

Key facts

HQUK
SectorBiotech
StatusActive

More from Eka Ventures Fund I

Other portfolio companies in the same fund.

32Co
Active
HealthTechUK· 2024
Airhive
Active
ClimateTechUK· 2024
MakeSense
MakeSense
Active
MedTechUK· 2024
XRlabs
XRlabs
Active
MedTechUK· 2024
Axle
Axle
Active
EnergyUK· 2023
Isla
Isla
Active
HealthTechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Oxford Cancer Analytics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Oxford Cancer Analytics?

4 strategic and 116financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Oxford Cancer Analytics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue